Correction: Gluco-Incretins Regulate Beta-Cell Glucose Competence by Epigenetic Silencing of Fxyd3 Expression

Correction: Gluco-Incretins Regulate Beta-Cell Glucose Competence by Epigenetic Silencing of Fxyd3 Expression

Bibliographic Details
Main Author:	The Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277473/?tool=EBI

Similar Items

Gluco-incretins regulate beta-cell glucose competence by epigenetic silencing of Fxyd3 expression.
by: David Vallois, et al.
Published: (2014-01-01)

Correction: Gluco-Incretins Regulate Beta-Cell Glucose Competence by Epigenetic Silencing of Expression.
Published: (2014-01-01)

Expression and Significance of FXYD-3 Protein in Gastric Adenocarcinoma
by: Zhen-Long Zhu, et al.
Published: (2010-01-01)

Role of fasting duration and weekday in incretin and glucose regulation
by: Kim K B Clemmensen, et al.
Published: (2020-04-01)

Impaired AQP2 trafficking in Fxyd1 knockout mice: A role for FXYD1 in regulated vesicular transport.
by: Elena Arystarkhova, et al.
Published: (2017-01-01)

Hepcidin links gluco-toxicity to pancreatic beta cell dysfunction by inhibiting Pdx-1 expression
by: Xuhua Mao, et al.
Published: (2017-03-01)

Novel Enteroendocrine Cell Receptors Regulating Incretin Secretion and Glucose Homeostasis
by: Flock, Grace
Published: (2012)

Novel Enteroendocrine Cell Receptors Regulating Incretin Secretion and Glucose Homeostasis
by: Flock, Grace
Published: (2012)

FXYD5: Na+/ K+-ATPase Regulator in Health and Disease.
by: Irina eLubarski Gotliv
Published: (2016-03-01)

The degradation of methyl beta-D-gluco-pyranoside by oxygen in alkaline solution
by: McCloskey, John T.
Published: (2005)

AMPK is involved in the regulation of incretin receptors expression in pancreatic islets under a low glucose concentration.
by: Kazuki Tajima, et al.
Published: (2013-01-01)

FXYD3: A Promising Biomarker for Urothelial Carcinoma
by: ZhongFa Zhang, et al.
Published: (2011-02-01)

FXYD proteins, the regulator of Na+, K+-ATPase of the euryhaline teleost, Tetraodon nigroviridis
by: Pei-Jen Wang, et al.
Published: (2010)

Structural and functional investigation of Na+, K+-ATPase regulators : FXYD proteins and cardiac glycosides
by: Whittaker, Christopher Andrew Paul
Published: (2011)

Expression and potential role of FXYD proteins in the saltwater model brackish medaka, Oryzias dancena
by: Wen-Kai Yang, et al.
Published: (2013)

Effect of differentiation, de novo innervation, and electrical pulse stimulation on mRNA and protein expression of Na+,K+-ATPase, FXYD1, and FXYD5 in cultured human skeletal muscle cells.
by: Vid Jan, et al.
Published: (2021-01-01)

Correction: A Position Effect on the Heritability of Epigenetic Silencing
by: Jaswinder Singh, et al.
Published: (2009-02-01)

Correction: A Position Effect on the Heritability of Epigenetic Silencing.
by: Jaswinder Singh, et al.
Published: (2009-02-01)

System Accuracy Evaluation of the GlucoRx Nexus Voice TD-4280 Blood Glucose Monitoring System
by: Muhammad Khan, et al.
Published: (2014-01-01)

Inflammation and Incretins
by: Amitabh Hatwal
Published: (2012-01-01)

FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis
by: Chen Xiongfei, et al.
Published: (2020-04-01)

Overexpression of FXYD-3 Is Involved in the Tumorigenesis and Development of Esophageal Squamous Cell Carcinoma
by: Zhen-Long Zhu, et al.
Published: (2013-01-01)

FXYD3 and TNFα mRNA Expression in Laryngeal Squamous Cell Carcinoma and their Correlation with Clinicopathologic Parameters
by: Somayeh Dadras, et al.
Published: (2016-10-01)

Retracted: System Accuracy Evaluation of the GlucoRx Nexus Voice TD-4280 Blood Glucose Monitoring System
by: Disease Markers
Published: (2015-01-01)

Comment on “System Accuracy Evaluation of the GlucoRx Nexus Voice TD-4280 Blood Glucose Monitoring System”
by: Nilesh Nathwani
Published: (2015-01-01)

Effectiveness of continuous glucose monitoring during diabetic pregnancy (GlucoMOMS trial); a randomised controlled trial
by: Voormolen Daphne N, et al.
Published: (2012-12-01)

FXYD8, a Novel Regulator of Renal Na+/K+-ATPase in the Euryhaline Teleost, Tetraodon nigroviridis
by: Pei-Jen Wang, et al.
Published: (2017-08-01)

FXYD6 Regulates Chemosensitivity by Mediating the Expression of Na+/K+-ATPase α1 and Affecting Cell Autophagy and Apoptosis in Colorectal Cancer
by: Wen Luo, et al.
Published: (2021-01-01)

Epigenetic silencing of a multifunctional plant stress regulator
by: Mark Zander, et al.
Published: (2019-08-01)

Regulation of Ubx expression by epigenetic enhancer silencing in response to Ubx levels and genetic variation.
by: Michael A Crickmore, et al.
Published: (2009-09-01)

FXYD5 Is an Essential Mediator of the Inflammatory Response during Lung Injury
by: Patricia L. Brazee, et al.
Published: (2017-06-01)

Salinity effects on expression of Na+, K+-ATPase and FXYD proteins in the kidney of euryhaline milkfish, Chanos chanos
by: Tse-Lih Chao, et al.
Published: (2017)

Molecules of Silence: Effects of Meditation on Gene Expression and Epigenetics
by: Sabrina Venditti, et al.
Published: (2020-08-01)

Effects of meal and incretins in the regulation of splanchnic blood flow
by: Jukka Koffert, et al.
Published: (2017-04-01)

Cloning, Expression, and Complete nucleotide sequence of Gluco- nobacter oxydans recA gene
by: Chao, Der Jiang, et al.

Structure and properties of totally synthetic galacto- and gluco-cerebrosides
by: Kumkum Saxena, et al.
Published: (1999-05-01)

Pleiotropic effects of incretins
by: Vishal Gupta
Published: (2012-01-01)

Epigenetic Silencing of DKK3 in Medulloblastoma
by: André Oberthuer, et al.
Published: (2013-04-01)

Frequent epigenetic silencing of the folate-metabolising gene cystathionine-beta-synthase in gastrointestinal cancer.
by: Hong Zhao, et al.
Published: (2012-01-01)

The effect of different grazing conditions on the insulin and incretin response to the oral glucose test in ponies
by: Danielle M. Fitzgerald, et al.
Published: (2019-10-01)